|
The latest insights into rare blood disorders: Diagnosis and treatment strategies
Because immune-mediated rare blood disorders are uncommon, healthcare providers often lack the knowledge and experience necessary to identify, diagnose, and treat them in accordance with best practices. As a result, there are significant gaps in care, including delays in diagnosis and suboptimal treatment. To ensure that more patients with these rare disorders are offered quality, evidence-based care, it is essential that healthcare providers possess up-to-date information about best practices... |
|
Addressing Key Questions About BCMA-Targeted Therapy for Relapsed/Refractory Multiple Myeloma
ACTIVITY DESCRIPTION
Though treatment advances have improved outcomes for most patients, MM remains an incurable disease characterized by continuous relapse. However, the treatment landscape for relapsed/refractory MM (RRMM) has expanded in recent years, and patients who relapse and/or become refractory to initial therapies are benefiting from the increasing availability of a diverse range of novel agents, including B-cell maturation antigen (BCMA)"targeted immunotherapies. These agents ... |
|
Recent Advances in the Treatment and Management of Endometrial Cancer
This live activity is designed for oncologists, obstetrics & gynecologists, primary care physicians, nurses and pharmacists engaged in the care of patients with endometrial cancer. This activity will represent a thorough team approach to patient care.
Further, this activity will address the following needs:
Clinicians require a review of risk factors and symptoms of endometrial cancer, as well as appropriate management of patients.
Clinicians need further education regarding new and... |
|
Across the Compendium: Practical Pathways to Integrate Bispecific Antibodies Into Care for Patients With Relapsed/Refractory Multiple Myeloma
As the armamentarium of therapies for relapsed/refractory multiple myeloma (R/R MM) expands, several factors, including previous therapy, treatment-related toxicity, and comorbidities must be considered as part of clinical decision making. To assist the multidisciplinary treatment team in these efforts, and ensure patients are receiving cutting-edge cancer care, this immersive digital practice guide highlights best practices, clinical pearls, and strategies to overcome pitfalls in the administ... |
|
Nuclear Medicine and Molecular Imaging Update
The Mid East Chapter of the Society of Nuclear Medicine and Molecular Imaging’s historic 50th Annual Conference presents nuclear medicine’s latest trends, advances and procedures. Adapted for the enduring material audience, Nuclear Medicine and Molecular Imaging Update features a dozen faculty members presenting this specialty’s impact on imaging, cardiology, neurology, endocrinology, oncology, rheumatology, pediatrics and much more. Practice enhancements and professional development w... |
|
Biosimilars in Osteoporosis: Highlights from the ASBMR
Biosimilars are large, complex molecules made from living organisms that are highly similar to their reference biologic and are administered in the same way, with the same strength and dosage, and clinically meaningful differences in safety, purity, and potency.
Incorporating biosimilars into the management of osteoporosis, known as a silent chronic disease responsible for 13 million fragility fractures worldwide, provide a more affordable version of osteoporosis medication, and an alternat... |
|
Cancer Treatment Related Cognitive Impairment - Connie Carson, PhD, CCC-SLP
Oncology professionals, nurses, neuropsychologists, and psychologists have established cancer treatment related cognitive impairment (CTRCI) as a common side-effect of cancer treatment, impacting as many as 75% of cancer survivors; yet, speech-language pathologists have been silent in establishing their role in the treatment of this phenomenon. This presentation will provide the necessary background for them to be able to do so. Clinical symptoms will be defined and therapeutic suggestions off... |
|
Cultural Awareness in Clinical Practice
Cultural Awareness in Clinical Practice is a 3-hour online continuing education (CE) course that provides the foundation for achieving cultural competence and diversity in healthcare settings.
Cultural competence, responding to diversity and inclusion, are important practices for healthcare professionals. This course will help you to gain an awareness of bias and provide strategies to adjust your clinical mindset and therapeutic approach to adapt to “the other” " people who differ ... |
|
HIV/AIDS: Therapy & Adherence
HIV/AIDS: Therapy & Adherence is a 3-hour online continuing education (CE/CEU) course that reviews treatment and adherence issues in populations at high risk for HIV infection.
People who live with HIV can live almost normal lifespans and have little risk of transmitting the disease if they use antiretroviral therapy appropriately under medical care. However, only 57% of people infected with HIV follow their antiretroviral regimen well enough to achieve viral suppression.
In this co... |
|
Aging: Challenges for Clinicians
Aging: Challenges for Clinicians is a 3-hour online continuing education (CE) course that provides a review of the aging process, illustrating potential challenges and effective solutions.
There are proportionately more older adults living now than in previous generations due to the post-World War II baby boom. Americans are also living longer, well into their eighties, nineties, and beyond. In healthcare, the volume of older people may soon outnumber the supply of healthcare professionals ... |